- AU$7.17bn
- AU$8.66bn
- AU$145.90m
- 74
- 45
- 59
- 63
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.33 | ||
| PEG Ratio (f) | 0.75 | ||
| EPS Growth (f) | 34.68% | ||
| Dividend Yield (f) | 8.75% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.14 | ||
| Price to Tang. Book | 1.76 | ||
| Price to Free Cashflow | 77.82 | ||
| Price to Sales | 49.12 | ||
| EV to EBITDA | 93.36 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.36% | ||
| Return on Equity | 4.39% | ||
| Operating Margin | -19.81% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 106.65 | 100.66 | 118.2 | 134 | 145.9 | 189.64 | 196.73 | -3.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +15.83 | -20.51 | -4.6 | +42.58 | +21.67 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Atlas Arteria Group is an Australia-based global owner, operator, and developer of toll roads. The Company has a portfolio of five toll roads in France, Germany, and the United States. The Company owns a 31.14% interest in the Autoroutes Paris-Rhin-Rhone (APRR) toll road group in France. In addition to the APRR business is the smaller Autoroute des deux lacs (ADELAC) business, which connects to APRR in southeast France. Together APRR and ADELAC comprise approximately 2,424 kilometers of motorway network located in the East and Southeast of France. In the United States, it owns a 66.67% interest in the Chicago Skyway, a 12.5 kilometers toll road in Chicago and has 100% of the economic interest in the Dulles Greenway, a 22 kilometers toll road in the Commonwealth of Virginia. In Germany, it owns 100% of the Warnow Tunnel in the northeast city of Rostock.
Directors
- Jeffrey Conyers NEC (67)
- Debra Goodin NEC (54)
- Graeme Bevans CEO (62)
- Nadine Lennie CFO
- Vincent Portal-Barrault COO
- Clayton McCormack GCN
- Paul Lynch SEC
- Ariane Barker NID
- David Bartholomew NID (60)
- Fiona Beck NID (56)
- Andrew Cook NID (58)
- Caroline Foulger NID (60)
- Jean-Georges Malcor NID (64)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 1st, 1970
- Public Since
- January 25th, 2010
- No. of Shareholders
- 21,496
- Sector
- Transport Infrastructure
- Industry
- Industrials
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 1,450,833,707
- Address
- Level 1, 180 Flinders Street, MELBOURNE, 3000
- Web
- https://www.atlasarteria.com/
- Phone
- +61 800621694
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for ALX
Atlas Arteria Group Annual Shareholders Meeting
Atlas Arteria Group Annual Shareholders Meeting
Q2 2025 Atlas Arteria Group Traffic and Revenue Data
Half Year 2025 Atlas Arteria Group Earnings Release
Similar to ALX
Auckland International Airport
Australian Stock Exchange - SEATS
Bhagwan Marine
Australian Stock Exchange - SEATS
Dalrymple Bay Infrastructure
Australian Stock Exchange - SEATS
Qube Holdings
Australian Stock Exchange - SEATS
Smart Parking
Australian Stock Exchange - SEATS
FAQ
What is the Atlas Arteria share price?
As of Today at 19:24 UTC, shares in Atlas Arteria are trading at AU$4.94. This share price information is delayed by 15 minutes.
How has the Atlas Arteria share price performed this year?
Shares in Atlas Arteria last closed at AU$4.94 and the price had moved by -6.62% over the past 365 days. In terms of relative price strength the Atlas Arteria share price has underperformed the ASX All Ordinaries Index by -8.05% over the past year.
What are the analyst and broker recommendations for Atlas Arteria?
The overall consensus recommendation for Atlas Arteria is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Atlas Arteria dividend yield?
The Atlas Arteria dividend yield is 8.1% based on the trailing twelve month period.
Does Atlas Arteria pay a dividend?
Last year, Atlas Arteria paid a total dividend of AU$0.40, and it currently has a trailing dividend yield of 8.1%. We do not have any data on when Atlas Arteria is to next pay dividends.
When does Atlas Arteria next pay dividends?
We do not have data on when Atlas Arteria is to next pay dividends. The historic dividend yield on Atlas Arteria shares is currently 8.1%.
How do I buy Atlas Arteria shares?
To buy shares in Atlas Arteria you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Atlas Arteria?
As of the previous close price of AU$4.94, shares in Atlas Arteria had a market capitalisation of AU$7.17bn.
Where are Atlas Arteria shares listed?
Here are the trading details for Atlas Arteria:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ALX
What kind of share is Atlas Arteria?
Based on an overall assessment of its quality, value and momentum Atlas Arteria is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Atlas Arteria share price forecast for 2025?
The analyst consensus target price for shares in Atlas Arteria is AU$5.29. That is 7.02% above the last closing price of AU$4.94.
Analysts covering Atlas Arteria currently have a consensus Earnings Per Share (EPS) forecast of AU$0.24 for the next financial year.
Find out moreWhat is the trend in the Atlas Arteria share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Atlas Arteria. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +6.61%.
As of the last closing price of AU$4.94, shares in Atlas Arteria were trading +0.05% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Atlas Arteria PE Ratio?
The Atlas Arteria PE ratio based on its reported earnings over the past 12 months is 19.33. The shares last closed at AU$4.94.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Atlas Arteria?
Atlas Arteria's management team is headed by:
- Jeffrey Conyers - NEC
- Debra Goodin - NEC
- Graeme Bevans - CEO
- Nadine Lennie - CFO
- Vincent Portal-Barrault - COO
- Clayton McCormack - GCN
- Paul Lynch - SEC
- Ariane Barker - NID
- David Bartholomew - NID
- Fiona Beck - NID
- Andrew Cook - NID
- Caroline Foulger - NID
- Jean-Georges Malcor - NID